Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry
Pharmaceuticals | Free Full-Text | Levetiracetam Mechanisms of Action: From Molecules to Systems
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond | SpringerLink
Pharmaceuticals | Free Full-Text | Levetiracetam Mechanisms of Action: From Molecules to Systems
Padsevonil: A Promising Option for Intractable Epilepsy
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry
Pharmaceuticals | Free Full-Text | Levetiracetam Mechanisms of Action: From Molecules to Systems
Frontiers | Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking - ScienceDirect
Pharmaceuticals | Free Full-Text | Levetiracetam Mechanisms of Action: From Molecules to Systems
Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy - Bryson - 2023 - Journal of Neurochemistry - Wiley Online Library
Rafal KAMINSKI | CSO | MD, PhD | Research profile
Proceedings of the 15th Antiepileptic Drug and Device Trials Meeting: State of the Science - Epilepsy & Behavior
Predicted versus observed PSL plasma concentrations. Predicted values... | Download Scientific Diagram
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond | SpringerLink
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor | Journal of Pharmacology and Experimental Therapeutics
Padsevonil | C14H14ClF5N4O2S | CID 52911611 - PubChem
IJMS | Free Full-Text | In Vivo and In Vitro Characterization of Close Analogs of Compound KA-11, a New Antiseizure Drug Candidate
PROTOCOL EP0091 AMENDMENT 2 ARISE: pAdsevonil in drug-ResIStant Epilepsy A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE FI
Frontiers | The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
PDF) Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor | Journal of Pharmacology and Experimental Therapeutics
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models | Journal of Pharmacology and Experimental Therapeutics
Frontiers | Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Pharmaceuticals | Free Full-Text | Levetiracetam Mechanisms of Action: From Molecules to Systems
Padsevonil (UCB-0942) | Cas# 1294000-61-5 - GlpBio
PDF) Pharmacological profile of the antiepileptic drug candidate padsevonil – characterization in rodent seizure and epilepsy models
